Guanfacine Hydrochloride Extended-Release for the Treatment of Attention Deficit Hyperactivity Disorder in Adults: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines

Icon for NCBI Bookshelf Related Articles

Guanfacine Hydrochloride Extended-Release for the Treatment of Attention Deficit Hyperactivity Disorder in Adults: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines

Book. 2018 09 11

Authors: Poitras V, McCormack S

Abstract
The purpose of this report is to examine the clinical effectiveness, cost-effectiveness, and evidence-based guidelines regarding the use of guanfacine hydrochloride extended-release for the treatment of adults with attention deficit hyperactivity disorder (ADHD).

PMID: 30840418

via https://www.ncbi.nlm.nih.gov/pubmed/30840418?dopt=Abstract